United States

Jackpot! California cannabis commission releases report today

The Center for Cannabis Research at the University of California has weighed in today with a report on original scientific research on the therapeutic value of marijuana or cannabis. The Center was created to advise the California Legislature about marijuana.

I have long thought that the principal problem with medical marijuana is that it kind of exists in an "evidence-free" zone. The publication of this document summarizing multiple different clinical research studies on medical marijuana.

FDA cracks down on therapeutic ozone devices

I have had people take hyperbaric oxygen therapy for foot ulcers with some success, but otherwise had no idea these things were being used to treat cancer, AIDS, and other illnesses.  The Cochrane Review looks to be gearing up to review the use of ozone in diabetic foot ulcers soon, stay tuned for some of their usually definitive coverage. 

Doctors purveying questionable therapies: if you're not careful, the FDA will sic the US Marshals on you!

Terms and Conditions of Use InteractMD.com

By using this site you signify that you have read and assent to these Terms and Conditions of Use. If you do not agree to follow all of the Terms and Conditions of Use do not use this site. InteractMD.com (InteractMD.com) reserves the right to update these Terms and Conditions of Use at any time. Your continued use of the InteractMD.com website means that you accept those changes. This site does not provide medical advice.

Novel Hsp90 Inhibitor to Begin Phase 1 Study in Cancer Patients

Salt Lake City April 8 2009 -- Myriad Pharmaceuticals Inc. announced today that the FDA has approved an Investigational New Drug (IND) application to begin a Phase 1 clinical study with its Hsp90 inhibitor MPC-3100 for the treatment of cancer. The clinical development plan for MPC-3100 is designed to expedite the drug candidate through the clinical development path. The Phase 1 trial will assess the safety and pharmacokinetics profile of MPC-3100.

Thyroid cancer: a review

Where is the thyroid gland and what is it’s function? The thyroid gland is shaped like a butterfly and sits just below the voice box and in front of the trachea (wind-pipe). It resides under thin muscle layers in the midline central neck just above the sternum and moves with swallowing as it is attached to the trachea. The thyroid gland is a central organ in the body that secretes thyroid hormones and as such regulates our body’s metabolism energy level and various other functions.

Leukemia drug shows activity--for MS!

Multiple sclerosis (MS) is the most common neurological disorder which affects the brain and spinal cord of generally young persons. Majority of researchers consider it as an "autoimmune disease” in which white blood cells intend to fight infection or disease are mistaken to target and attack the body's own cells. MS affects almost 400 000 people in the United States and quite a few million worldwide. Many useful medications are available for the treatment of MS.

Rituximab shows efficacy in rheumatoid arthritis in randomized trials

Rheumatoid arthritis (RA) is an agonizing autoimmune disorder of uncertain origin leading to chronic inflammation at the joints. RA develops in three stages. Nearly 46 million Americans or more than 21 percent of the adult population are affected by this disorder. The origin of RA is unknown but the disease can be controlled by way of new drugs exercise joint protection skills and self-management techniques.

Coronary CT fares well compared with conventional angiography in NEJM article

According to American Heart Association more than 1.2 million patients in the U.S. go through cardiac angiograms every year and out of which 1 to 2% of cases results in complications and nearly 25 people die every year with this process. A new study published in the New England Journal of Medicine (NEJM) however has revealed that noninvasive CT scans are almost as precise at imaging coronary artery blockages as against traditional angiography and are much safer for the patients.

Diabetes drugs implicated in bone fracture risk

A new study published in the December 10 online issue of the Canadian Medical Association Journal reports that continued use of well known oral diabetes GlaxoSmithKline's drugs Avandia (rosiglitazone) and Actos (pioglitazone) almost doubles the risk of bone fractures in women with type 2 diabetes. Researchers had been aware that two thiazolidinedione (TZD) drugs for diabetes were correlated with fractures but the scope of the risk was not known. That is the reason why a study was constituted to know the efficacy of the diabetes drug. The lead researcher Dr.

Syndicate content